Robert N. Atkinson - Concepedia

Author

Robert N. Atkinson

Also Known As

Atkinson, R.N., R Atkinson, R. Atkinson, R. N. ATKINSON, R. N. Atkinson, R.N. Atkinson, Robert Atkinson, Robert N Atkinson, Robert N. Atkinson

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

RTI International Wake Forest University Abbott Fund Eli Lilly (United States)Abbott (United States)

About

Robert N. Atkinson is an author at RTI International specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	288
2	Biochemistry	5	5	149
3	Natural Sciences	3	3	56
4	Health Sciences	2	2	105
5	Social Sciences	1	1	56

Robert N. Atkinson

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A-803467, a potent and selective Na <sub>v</sub> 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat Michael F. Jarvis, Prisca Honoré, Char‐Chang Shieh, Proceedings of the National Academy of Sciences	2007	514
Identification of the First <i>trans</i>-(3<i>R</i>,4<i>R</i>)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist Activity James B. Thomas, Robert N. Atkinson, Richard B. Rothman, Journal of Medicinal Chemistry	2001	105
Discovery and Biological Evaluation of 5-Aryl-2-furfuramides, Potent and Selective Blockers of the Na<sub>v</sub>1.8 Sodium Channel with Efficacy in Models of Neuropathic and Inflammatory Pain Michael E. Kort, Irene Drizin, Robert J. Gregg, Journal of Medicinal Chemistry Pain DisordersPain MedicineNeuropathic PainMolecular PainPharmacotherapy	2008	83
Percutaneous Kirschner Wire Stabilisation following Closed Reduction of Colles’ Fractures E. T. Mah, Robert N. Atkinson Journal of Hand Surgery (European Volume)	1992	79
Identification of (3<i>R</i>)-7-Hydroxy-<i>N</i>-((1<i>S</i>)-1-{[(3<i>R</i>,4<i>R</i>)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a Novel Potent and Selective Opioid κ Receptor Antagonist James B. Thomas, Robert N. Atkinson, N. Ariane Vinson, Journal of Medicinal Chemistry	2003	75
A-887826 is a structurally novel, potent and voltage-dependent Nav1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats Xu‐Feng Zhang, Char‐Chang Shieh, Mark L. Chapman, Neuropharmacology Molecular PharmacologyNeurophysiologySodium HomeostasisSynaptic TransmissionPhysiology	2010	56
Generation of Acyl Nitroso Compounds by the Oxidation of N-Acyl Hydroxylamines with the Dessmartin Periodinane Neil Jenkins, Roy W. Ware, Robert N. Atkinson, Synthetic Communications	2000	55
Synthesis and Nicotinic Acetylcholine Receptor Binding Properties of Bridged and Fused Ring Analogues of Epibatidine F. Ivy Carroll, T. Philip Robinson, Lawrence E. Brieaddy, Journal of Medicinal Chemistry	2007	40
Reactions of acyl nitroso compounds with amines: Production of nitroxyl (HNO) with the preparation of amides Robert N. Atkinson, Bernadette M Storey, S. Bruce King Tetrahedron Letters Cross-coupling ReactionOrganic ChemistryAcyl Nitroso CompoundsChemistrySynthetic Chemistry	1996	37
Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Nav1.8 sodium channel with efficacy in a model of neuropathic pain Marc J. C. Scanio, Lei Shi, Irene Drizin, Bioorganic & Medicinal Chemistry Nav1.8 Sodium ChannelPyrazine-based BlockersPain MedicinePharmacologyNeuropathic Pain	2010	33

Page 1